Industrialization of Quantitative Systems Pharmacology

被引:1
作者
Topp, Brian [1 ]
Trujillo, Maria E. [1 ]
Sinha, Vikram [1 ]
机构
[1] Merck & Co Inc, Merck Res Labs, Quantitat Pharmacol & Pharmacometr, Pharmacokinet Pharmacodynam & Drug Metab, Kenilworth, NJ 07033 USA
来源
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY | 2019年 / 8卷 / 06期
关键词
MODEL;
D O I
10.1002/psp4.12427
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
As a result of our limited understanding of human pathophysiology, many drugs never become medicines. The use of quantitative systems pharmacology (QSP) has seen many advances with the goal of improving the probability of technical success. Many research and development (R&D) organizations have invested in QSP models; however, areas that require continuous efforts are best practices, training, education, and the clear understanding of regulatory expectations.
引用
收藏
页码:356 / 358
页数:3
相关论文
共 50 条
  • [21] Leveraging systems biology approaches in clinical pharmacology
    Melas, Ioannis N.
    Kretsos, Kosmas
    Alexopoulos, Leonidas G.
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2013, 34 (09) : 477 - 488
  • [22] Systems Pharmacology: Defining the Interactions of Drug Combinations
    van Hasselt, J. G. Coen
    Iyengar, Ravi
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59, 2019, 59 : 21 - 40
  • [23] A Quantitative Systems Pharmacology Framework for Optimal Doxorubicin Granulocyte Colony-Stimulating Factor Regimens in Triple-Negative Breast Cancer
    Paredes Bonilla, Rosalba Vivian
    Nekka, Fahima
    Craig, Morgan
    PHARMACOLOGY, 2021, 106 (9-10) : 542 - 550
  • [24] Implications of Immunogenicity Testing for Therapeutic Monoclonal Antibodies: A Quantitative Pharmacology Framework
    Williams, Jason H.
    Liao, Kai H.
    Yin, Donghua
    Meng, Xu
    AAPS JOURNAL, 2024, 26 (02)
  • [25] Pharmacology-based toxicity assessment: towards quantitative risk prediction in humans
    Sahota, Tarjinder
    Danhof, Meindert
    Della Pasqua, Oscar
    MUTAGENESIS, 2016, 31 (03) : 359 - 374
  • [26] The use of quantitative clinical pharmacology approaches to support moxidectin dosing recommendations in lactation
    Wood, Nolan D.
    Smith, Danelle
    Kinrade, Sally A.
    Sullivan, Mark T.
    Rayner, Craig R.
    Wesche, David
    Patel, Kashyap
    Rowland-Yeo, Karen
    PLOS NEGLECTED TROPICAL DISEASES, 2024, 18 (08):
  • [27] Emerging Role of Organ-on-a-Chip Technologies in Quantitative Clinical Pharmacology Evaluation
    Isoherranen, Nina
    Madabushi, Rajanikanth
    Huang, Shiew-Mei
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2019, 12 (02): : 113 - 121
  • [28] Quantitative Clinical Pharmacology of T-Cell Engaging Bispecifics: Current Perspectives and Opportunities
    Morcos, Peter N.
    Li, Junyi
    Hosseini, Iraj
    Li, Chi-Chung
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (01): : 75 - 85
  • [29] Bedside to Bench: Integrating Quantitative Clinical Pharmacology and Reverse Translation to Optimize Drug Development
    Gibbs, John P.
    Menon, Rajeev
    Kasichayanula, Sreeneeranj
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (02) : 196 - 198
  • [30] Heterogeneous Paths of Industrialization
    Huneeus, Federico
    Rogerson, Richard
    REVIEW OF ECONOMIC STUDIES, 2024, 91 (03) : 1746 - 1774